Metraipolis › archive › dc_f27019f147b0
Screening the Combination of Gemcitabine, Clomipramine, and Resveratrol in HL-60 Leukemia Cells — Europe PMC PMID:42193135
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42193135
- DOI
- 10.3390/cimb48050531
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T14:34:37.599Z
- SHA-256 of the archived text
6a0f59c1f3719ec5bf653c3860d86a72f98d4825d6589b24733c40f5570c8802- Stable URL of this page
https://metraipolis.com/documento/dc_f27019f147b0
How to cite
Screening the Combination of Gemcitabine, Clomipramine, and Resveratrol in HL-60 Leukemia Cells — Europe PMC PMID:42193135 — Europe PMC (en), https://europepmc.org/article/MED/42193135 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f27019f147b0 (Metraipolis archive dc_f27019f147b0, sha256 6a0f59c1f3719ec5bf653c3860d86a72f98d4825d6589b24733c40f5570c8802)
BibTeX
@misc{dcf27019f147b0,
title = {Screening the Combination of Gemcitabine, Clomipramine, and Resveratrol in HL-60 Leukemia Cells — Europe PMC PMID:42193135},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42193135},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f27019f147b0; sha256 6a0f59c1f3719ec5bf653c3860d86a72f98d4825d6589b24733c40f5570c8802},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42193135. Agents can read the archived copy with the MCP tool read_document.